 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TTK Healthcare Standalone September 2023 Net Sales at Rs 185.77 crore, up 9.41% Y-o-Y

Currently, promoters hold 75 percent in the company and public shareholders hold 25 percent

TTK Healthcare proposes delisting, 2 weeks after Sunil Singhania’s stake purchase

Abakkus has bought a total of 2.47 lakh equity shares in a stock which has been in an uptrend since March 2020 barring intermittent correction and consolidation.

Ace investor Sunil Singhania's Abakkus picks 1.74% stake in TTK Healthcare

TTK Healthcare Standalone December 2022 Net Sales at Rs 182.56 crore, down 14.09% Y-o-Y

TTK Healthcare Standalone September 2022 Net Sales at Rs 169.79 crore, down 17.72% Y-o-Y

TTK Healthcare Ltd. engages in the provision of consumer products. It operates through the following segments: Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices, Foods, and Others. The Pharmaceuticals segment offers products for both human, and veterinary use. The Consumer Products segment comprises of marketing and distribution of Woodward's Gripe Water, EVA range of cosmetics, good home range of scrubbers, and air fresheners. The Medical Devices segment covers artificial heart valves, orthopedic implant, and others. The Protective Devices segment produces and sells male contraceptives, and other allied products. The Foods segment manufactures food products. The Others segment consists of printing, and publishing of maps and atlases. The company was founded by Thiruvallur Thattai Krishnamachari in 1928 and is headquartered in Chennai, India.

Market Cap	19.2B
Volume (M)	13,002.00
52-Wk High	1,474.00
52-Wk Low	828.10

TTKHLTCARE.NSE TTK Healthcare Ltd.

About

Feed

News

Fundamentals